Mary Newman

Mary Newman appears in our data through filings on Audentes Therapeutics, Inc. shares, published by SEC (Form 4). Between 16 November 2017 and 15 November 2018, the trades on record add up to 15 filings.

The open-market record consists of 7 sales worth €771k, with no purchase. Outside the open market, there are 1 share grant and 7 option exercises. In 2018 alone, the filings show no purchases and 5 sales.

The latest filing, published on 16 November 2018, reports a share grant of €11k in Audentes Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.